×

Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means

  • US 9,139,828 B2
  • Filed: 11/11/2010
  • Issued: 09/22/2015
  • Est. Priority Date: 05/14/2008
  • Status: Active Grant
First Claim
Patent Images

1. An isolated antisense oligonucleotide consisting of 7, 8, 9, or 10 nucleotides and comprising the base sequence of 5′

  • -UCAGCUUCUGUUAGCCACUG-3′

    (SEQ ID NO;

         5), said oligonucleotide comprising a modification.

View all claims
  • 6 Assignments
Timeline View
Assignment View
    ×
    ×